Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 80
Titolo Data di pubblicazione Autori File
Neoadjuvant chemotherapy and radical radiotherapy associated with cetuximab for laryngeal cancer in a pancreas and renal recipient 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis 1-gen-2017 Roviello, GiandomenicoCorona, Silvia PaolaGenerali, Daniele
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 1-gen-2017 Sobhani, N.Ianza, A.Roviello, G.Mustacchi, G.Bortul, M.Zanconati, F.Generali, D. +
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility 1-gen-2017 ROVIELLO, GIANDOMENICOZANOTTI, LUCAZANCONATI, FABRIZIOGENERALI, DANIELE +
The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials 1-gen-2017 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Is still there a place for orteronel in management of prostate cancer? Data from a literature based meta-analysis of randomized trials 1-gen-2017 ROVIELLO, GIANDOMENICOCHIRIACÒ, GIOVANNIGENERALI, DANIELE +
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer 1-gen-2017 Corona, Silvia PaolaGenerali, DanieleRoviello, Giandomenico +
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy 1-gen-2017 Sobhani, NavidGenerali, DanieleRoviello, Giandomenico
Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer? 1-gen-2017 ROVIELLO, GIANDOMENICOGUGLIELMI, ALESSANDRAGENERALI, DANIELE +
Bevacizumab in small cell lung cancer 1-gen-2017 Roviello, GiandomenicoSobhani, NavidGenerali, Daniele
Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer? 1-gen-2017 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 1-gen-2017 SOBHANI, NAVIDROVIELLO, GIANDOMENICOCorona, S. P.IANZA, ANNAZANCONATI, FABRIZIOGENERALI, DANIELE
Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma 1-gen-2017 BONETTA, ARIANNAROVIELLO, GIANDOMENICOGENERALI, DANIELEZANOTTI, LUCA +
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies 1-gen-2017 Roviello, GiandomenicoGenerali, Daniele +
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 1-gen-2017 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer 1-gen-2017 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis 1-gen-2017 Roviello, GiandomenicoGenerali, Daniele
Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer? 1-gen-2017 Corona, Silvia PaolaRoviello, GiandomenicoGenerali, Daniele +
Advances in systemic therapy for malignant mesothelioma: Future perspectives 1-gen-2017 Sobhani, NavidCorona, Silvia PaolaBonazza, DeborahIanza, AnnaRoviello, GiandomenicoCortale, MaurizioGuglielmi, AlessandraZanconati, FabrizioGenerali, Daniele +
Mostrati risultati da 21 a 40 di 80
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile